Shareholder Alert: Robbins LLP Reminds Investors NMC Health Plc (NMHLY) Sued for Misleading Shareholders

Editorial & Advertiser Disclosure Global Banking And Finance Review is an independent publisher which offers News, information, Analysis, Opinion, Press Releases, Reviews, Research reports covering various economies, industries, products, services and companies. The content available on globalbankingandfinance.com is sourced by a mixture of different methods which is not limited to content produced and supplied by various staff writers, journalists, freelancers, individuals, organizations, companies, PR agencies Sponsored Posts etc. The information available on this website is purely for educational and informational purposes only. We cannot guarantee the accuracy or applicability of any of the information provided at globalbankingandfinance.com with respect to your individual or personal circumstances. Please seek professional advice from a qualified professional before making any financial decisions. Globalbankingandfinance.com also links to various third party websites and we cannot guarantee the accuracy or applicability of the information provided by third party websites. Links from various articles on our site to third party websites are a mixture of non-sponsored links and sponsored links. Only a very small fraction of the links which point to external websites are affiliate links. Some of the links which you may click on our website may link to various products and services from our partners who may compensate us if you buy a service or product or fill a form or install an app. This will not incur additional cost to you. A very few articles on our website are sponsored posts or paid advertorials. These are marked as sponsored posts at the bottom of each post. For avoidance of any doubts and to make it easier for you to differentiate sponsored or non-sponsored articles or links, you may consider all articles on our site or all links to external websites as sponsored . Please note that some of the services or products which we talk about carry a high level of risk and may not be suitable for everyone. These may be complex services or products and we request the readers to consider this purely from an educational standpoint. The information provided on this website is general in nature. Global Banking & Finance Review expressly disclaims any liability without any limitation which may arise directly or indirectly from the use of such information.

Shareholder rights law firm Robbins LLP reminds investors that a purchaser of NMC Health Plc (OTC: NMHLY) filed a class action complaint against the Company for alleged violations of the Securities Exchange Act of 1934 between March 13, 2016 and March 10, 2020. NMC provides healthcare services in the United Arab Emirates, the United Kingdom, Spain, and internationally.

If you suffered a loss as a result of NMC’s misconduct, click here.

NMC Health Plc (NMHLY) Accused of Misleading Shareholders

According to the complaint, from March 13, 2016 to March 6, 2019, NMC issued its annual reports for 2015, 2016, 2017, and 2018, each time affirming the Company’s “conservative approach in risk taking” and its implementation of “controls and mitigation strategies in order to reduce those risks,” and touting NMC’s internal controls. However, on December 17, 2019, Muddy Waters Capital LLC published a report revealing that NMC had failed to disclose: (i) its lack of internal controls; (ii) (de facto) related party transactions; (iii) its true debt burden; (iv) its true cash-on-hand and asset values; and (v) its use of reverse factoring. Finally, on March 10, 2020, Financial Times and Bloomberg published articles entitled “NMC Health Discovers Almost $3 billion of Debt Hidden from is Board” and “Abu Dhabi Insurer Steps In to Help NMC Health Pay Salaries,” respectively. As a result of all of these disclosures, NMC Health currently trades at around $1.20, representing a staggering 97% decline from its class period high of $53.03.

NMC Health Plc (NMHLY) Shareholders Have Legal Options

Contact us to learn more: Leo Kandinov (800) 350-6003 [email protected] Shareholder Information Form

Robbins LLP is a nationally recognized leader in shareholder rights law. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits, and has helped its clients realize more than $1 billion of value for themselves and the companies in which they have invested. Click here to receive free alerts from Stock Watch when companies engage in wrongdoing.

Attorney Advertising. Past results do not guarantee a similar outcome.

Leo Kandinov

Robbins LLP

5040 Shoreham Place

San Diego, CA 92122

[email protected]

(619) 525-3990 or Toll Free (800) 350-6003

www.robbinsllp.com